# Rifampin Combination Therapy Versus Monotherapy in Early Staphylococcal Infections After Total Hip and Knee Arthroplasty

> **NCT00423982** · PHASE4 · UNKNOWN · sponsor: **Oslo University Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Prosthesis-related Infections
- Staphylococcal Infections

## Interventions

- **DRUG:** Rifampin-combination therapy
- **DRUG:** Monotherapy

## Key facts

- **NCT ID:** NCT00423982
- **Lead sponsor:** Oslo University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-04
- **Primary completion:** 2012-12
- **Final completion:** 2014-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2013-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00423982

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00423982, "Rifampin Combination Therapy Versus Monotherapy in Early Staphylococcal Infections After Total Hip and Knee Arthroplasty". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00423982. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*